Path Exam 2 details

Hi everyone –

I’ve finalized the exam and I wanted to let you know the total number of questions and the breakdown per lecture, along with a few things to keep in mind as you’re reviewing the material.

There are 47 questions, roughly distributed according to the amount and density of information in each lecture, and the amount of lecture time devoted to each topic:

  • Gastrointestinal Pathology: 12
  • Pancreas, Liver and Gallbladder: 10
  • Skin: 10
  • Female Repro: 10
  • Male Repro: 5

All questions are multiiple choice, one correct answer, no photos.

When you’re studying, please make sure you know the answers to the lecture objectives for each lecture. And it would be a good idea to go through the five kahoots listed under Exam 2 on our Kahoots page.

Also, here are some little things to help with concepts that can be confusing:

The exam will take place during our normally-scheduled class time on Wednesday, 10/28, 8:00 – 9:55. I’ll bring little treats. The exam password is Shaboozey.

Be sure to bring your privacy screen. If you want to double check the classroom settings for Honorlock we’ll be using, you can take the mock exam on Canvas entitled “Practice Exam with Honorlock Proctoring Settings Off.”

And also: feel free to email me anytime with questions or concerns.

Pemphigus vulgaris vs. bullous pemphigoid

pemphigus

Here are a couple diseases with names that are maddeningly similar: pemphigus vulgaris and bullous pemphigoid. Both diseases have bullae (big blisters), and both are mediated by antibodies – but there are important differences that you need to remember.

There’s actually some logic behind the names of these diseases, and once you understand that, everything else falls into place. We talked about this in class – but I thought I’d share this post that I wrote, in case it helps to read about it in a different way.

Kahoots on all exam lectures now posted

Thank you to the student who let me know that the Kahoots section for this exam only had one Kahoot! I really appreciate it when you guys let me know if you see something amiss DURING our class, because then I can correct it in real time!

So I made and posted Kahoots on:

  • Upper and lower GI pathology
  • Liver, gallbladder and pancreatic pathology
  • Skin pathology
  • Female reproductive pathology
  • Male reproductive pathology

For the sake of time, I couldn’t cover all the objectives for each lecture. But at least it gives you something to look at that’s a little more active. There are some questions that are not multiple choice, just because I was feeling trapped making everything that way. But I will NOT try out new types of questions on our exam. They’ll all be multiple choice, one correct answer, as you know by now.

If you see a mistake please let me know so I can fix it right away!

How to remember what telangiectasia means

You guys know by now how much I like Latin and Greek word roots. I think they can really help you understand and remember diseases, especially when they occur in many disease names.

Telangiectasias are one of the potential symptoms of acne rosacea. This would be a really annoying word to try to learn without knowing any of the word roots.

So here’s the etymology of telangiectasia, along with some other examples using the same word roots.

Telangiectasia comes from three Greek words:

  • τέλος (telos): “end” (For example: telomeres are the little things on the ends of chromosomes.)
  • ἀγγεῖον (angeion): “vessel” (angio- is almost always used to indicate a blood vessel. For example: an angiogram is an imaging study that looks at blood vessels.)
  • ἐκτείνειν (ekteinein): “to extend” (any time you see ectasia or ectasis, it means an abnormal dilation of a tubular structure. For example: bronchiectasis means dilation of bronchi.)

So telangiectasias are abnormal dilations of the very ends (tiny capillaries or venules) of blood vessels.

How to do a breast self-exam

Breast self-exams are really important and should be done at least once a month. That way, you’ll become familiar with how your breasts look and feel, and you’ll be better able to tell if something has changed.

Breast cancer most commonly presents as a lump, so that’s the main thing you’re looking for. But sometimes, instead of a lump, there are other signs, as we talked about in class, like dimpling/puckering of the skin (if the cancer has attached itself to the skin or to the chest wall), or peau d’orange (thickening of the skin that resembles an orange peel). This procedure (below) involves examining your breasts in different positions, so you can detect all of these potential signs.

The National Breast Cancer foundation has a great step-by-step guide with detailed descriptions (good idea to check it out). Here’s a quick synopsis. There are three parts to the exam, each in a different place: in the shower, in front of a mirror, and lying down.

In the shower

Using the pads of your fingers, make small circular motions starting at the outer portion of your breast and moving in towards the center. Don’t forget the armpit!  Feel for lumps, thickening, or anything that feels different.

In front of a mirror

Look at your breasts first with your arms at your sides, then with your arms raised overhead, then with your hands on your hips as you flex your chest muscles. Look for dimpling, puckering, or any other changes. It’s normal for the breasts to not match exactly.

Lying down

Put a pillow under your right shoulder and put your right arm behind your head. Use the same procedure you used in the shower to examine the entire breast and the armpit. Also, squeeze the nipple and check for discharge (some cancers present with crusty lesions and nipple discharge). Repeat on the other side.

That’s it! Once you get used to how your breasts feel and look, it goes quickly.

Conjugated vs. unconjugated hyperbilirubinemia

In the Liver/Pancreas/Gallbladder lecture, I talked about the things that cause an elevation in serum bilirubin (hyperbilirubinemia).

I also talked about how it’s useful to know whether the patient has an elevation in conjugated or unconjugated bilirubin (because that helps you narrow down the possible causes).

Here’s a question and explanation to get you thinking about this a bit more.

While examining the gums of a 25 year old patient, a yellowish discoloration of the oral mucosa and sclera is noted.  Laboratory tests show a significant increase in unconjugated bilirubin.  Which of the following disorders is most likely the cause of this patient’s abnormalities?

A. A stone in the bile duct
B. Carcinoma of the head of the pancreas
C. Pancreatic pseudocyst
D. Sickle cell disease
E. Hepatocellular carcinoma

What’s the correct answer?

Let’s review a little before we get to the question.

Bilirubin is a breakdown product of heme (which, in turn is part of the hemoglobin molecule that is in red blood cells). It is a yellow pigment that is responsible for the yellow color of bruises, and the yellowish discoloration of jaundice.

When old red cells pass through the spleen, macrophages eat them up and break down the heme into unconjugated bilirubin (which is not water soluble). The unconjugated bilirubin is then sent to the liver, which conjugates the bilirubin with glucuronic acid, making it soluble in water. Most of this conjugated bilirubin goes into the bile and out into the small intestine. (An interesting aside: some of the conjugated bilirubin remains in the large intestine and is metabolized into urobilinogen, then sterobilinogen, which gives the feces its brown color! Now you know.)

So: if you have an increase in serum bilirubin, it could be either because you’re making too much bilirubin (usually due to an increase in red cell breakdown) or because you are having a hard time properly removing bilirubin from the system (either your bile ducts are blocked, or there is a liver problem, like cirrhosis, hepatitis, or an inherited problem with bilirubin processing).

The lab reports the total bilirubin, and also the percent that is conjugated (this is usually called the “direct” bilirubin). You can easily figure out, then, how much unconjugated bilirubin you have (it’s just the total bilirubin minus the direct bilirubin).

If you have a lot of bilirubin around and it is mostly unconjugated, that means that it hasn’t been through the liver yet – so either you’ve got a situation where you’ve got a ton of heme being broken down (and it’s exceeding the pace of liver conjugation), or there’s something wrong with the conjugating capacity of the liver (for example, the patient has hepatitis and it’s interfering with the liver’s ability to conjugate bilirubin).

If you have a lot of bilirubin around and it’s mostly conjugated, that means it’s been through the conjugation process in the liver – so there’s something preventing the secretion of bilirubin into the bile (for example, there’s something blocking the bile duct, or the patient has hepatitis and it’s interfering with bilirubin excretion), and the bilirubin is backing up into the blood.

Back to the question. Let’s go through each answer and see what kind of hyperbilirubinemia these disorders would cause.

A. A stone in the bile duct – if big enough, a stone here could block the excretion of bilirubin into the bile. The bilirubin would already be conjugated, so this would be a conjugated bilirubinemia.

B. Carcinoma of the head of pancreas – this could also cause biliary obstruction, similar to A. (An important aside: it’s nice when pancreatic carcinomas announce themselves this way, because it may allow for earlier detection of the tumor. Unfortunately, this is uncommon. Pancreatic adenocarcinoma is usually silent until the tumor is very large and possibly metastatic.)

C. Pancreatic pseudocyst – same idea as A and B.

D. Sickle cell disease – Sickle cell anemia is a type of hemolytic anemia. Hemolytic anemias often cause unconjugated bilirubinemia (when the hemolysis is massive enough, it’s hard for the liver to keep up, and you get a bunch of unconjugated bilirubin spilling into the blood. If there is just a little hemolysis going on, the liver may be able to keep up and conjugate that extra bilirubin, in which case you’d excrete the conjugated bilirubin normally (through the poopy).

E. Hepatocellular carcinoma – this would fall into the category of blocking excretion of bilirubin. The bilirubin would already be conjugated – so this would be a conjugated hyperbilirubinemia.

So: since A, B, C and E produce only conjugated hyperbilirubinemia, the answer is D, sickle cell disease.

Exam 1 corrections!

Everyone is now done with exam 1 (yay! great job!!). I want to let you know that there were some questions that were new this year, and they had errors in them. I’ll list each question, along with an explanation of what went wrong, and how I’m going to address the errors.

Question 25

Explanation: although we didn’t talk about it in class, asbestos exposure is related to lung cancer!

Fix for this question: accept both the original answer AND the answer about asbestos exposure.

Question 30

Explanation: This question has a big typo that basically made all the answers incorrect 😦 What I meant to say in the stem was that a child had edema, LOW (NOT HIGH) serum albumin, and high serum lipids with a normal-appearing renal biopsy. That would have been a great definition of minimal change disease – except in that disorder, serum protein (including albumin) is LOW, not high.

Here are two relevant questions from the renal path lecture (slides 11 and 12):


Fix for this question: delete question from exam, since there is no correct answer.

Question 31

Explanation: I was thinking just of IgA nephropathy, but the way the question stem is worded, both IgA nephropathy and post-infectious (post-streptococcal) glomerulonephritis are correct.

Fix for this question: Both IgA nephropathy and post-infectious (post-streptococcal) glomerulonephritis will be accepted as correct.

Bottom line

Okay – that’s it for questions – whew! I’m not allowed to rescore the exam until I return from vacation – so unfortunately you won’t see your Canvas score change for a few weeks. But you can determine, from the above information, what your new score will be on your own 🙂

Email me if you have any questions or comments!

Added learning objectives for lower GI and Liver/GB/Pancreas

I just added learning objectives to both of these lectures, and re-uploaded the ppts and pdfs. Sorry about that! I’ll be posting more soon but I know you guys have been waiting for these so I wanted to let you know now. There is a TON of stuff in the Liver/GB/Pancreas lecture – and rather than writing skimpy objectives that leave out important stuff, I decided to err on the side of too many LOs.

Path Exam 1 details

Hi everyone –

I promised to give you the number of questions on the test, and the breakdown per lecture. Here it is. There are 35 total questions, roughly distributed according to the amount of information in each lecture:

  • Blood vessels: 5
  • Heart 1 (heart failure, congestive heart disease, and ischemic heart disease): 7
  • Heart 2 (valvular disease, congenital heart disease, and tumors): 3
  • Respiratory pathology: 10
  • Renal Pathology: 10

All questions are multiiple choice, one correct answer, no photos.

When you’re studying, please make sure you know the answers to the lecture objectives for each lecture. And it would be a good idea to go through the four kahoots listed under Exam 1 on our Kahoots page. I just ran through each of the existing kahoots to make sure there weren’t any mistakes or questions covering material we didn’t cover this year. So they’re accurate 🙂 Also, take a look at my latest post which is a quick review of shunts and Eisenmenger syndrome just to be sure you understand these concepts.

Remember: the exam is now in-person, in our classroom, during our normally-scheduled class time (Wednesday, 9/30, from 9:05 to 11:00. Be sure to bring your privacy screen. If you want to double check the classroom settings for Honorlock we’ll be using, you can take the mock exam on Canvas entitled “Mock Exam with in-class settings (no camera/audio monitoring).”

And also: feel free to email me anytime with questions or concerns.